Imperial startup Biocentis to develop genetic tech to control harmful insects
Biocentis has received investment to use CRISPR-based gene-editing to control insect populations that harm health, food security and biodiversity.
2
Parasite-detecting DNA biosensors offer new tool to tackle schistosomiasis
Researchers have developed new DNA biosensors capable of rapidly detecting and differentiating between parasites that cause schistosomiasis.
Monkeypox outbreak - an Imperial expert explains
The UK Health Security Agency is investigating four new cases of monkeypox in the UK. There are now a total of six confirmed cases.
Low-cost, disease-detecting biosensors show global health promise
Researchers have developed low-cost, biodegradable biosensors for global health applications in resource-limited settings.
Inexpensive and rapid tests can distinguish between Chagas disease parasites
A new rapid diagnostic test that can differentiate between different strains of Chagas disease parasite could lead to a widespread testing programme.
1
ICB CDT student awarded BBSRC Flexible Talent Mobility Innovation Placement
ICB CDT student Mark Wilkinson has been awarded a BBSRC FTMA Innovation Placement and will spend 3 months attending the DDW unit at GSK, Madrid.
Imperial launches its first public health online degree
The Global Master of Public Health, developed alongside Coursera, is Imperial's first fully-online degree in the health field.
Experts reveal patterns of yellow fever risk, and warn against ignoring disease
Yellow fever kills around 80,000 people every year - and causes severe disease in a further 150,000.
1
Strengthening health systems to tackle schistosomiasis
SCI has been working with the Ministry of Health in Cote d'Ivoire to strengthen and develop its health systems to help combat schistosomiasis.
SCI recommended as a "Top Charity" for 7th consecutive year
GiveWell, an international charity evaluator, has recommended the SCI as a "Top Charity" once more for its impact and cost-effectiveness.
